Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma: best treatment options.

B B Wray1

  • 1Allergy-Immunology Section, Medical College of Georgia, Augusta 30912-3790, USA. Bettyw@mail.mcg.edu

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|July 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.

The New England journal of medicine·2016
Same author

Ever since I had a severe allergic reaction to a bee sting three years ago, I have been receiving allergy shots for insect venom. When, if ever, can I discontinue the injections?

Health news (Waltham, Mass.)·2000
Same author

No evidence-based medicine.

Pediatrics·1998
Same author

Hypersensitivity reactions to Escherichia coli-derived polyethylene glycolated-asparaginase associated with subsequent immediate skin test reactivity to E. coli-derived granulocyte colony-stimulating factor.

The Journal of allergy and clinical immunology·1998
Same author

Lethargy, fever, and hyponatremia in a patient with common variable immunodeficiency.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1997
Same author

Immunotherapy for asthma.

The New England journal of medicine·1997

Asthma management involves understanding chronic inflammation and utilizing new therapies. Early immunotherapy may prevent severe asthma progression by reducing airway reactivity.

Area of Science:

  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Asthma is a chronic inflammatory airway disease with evolving therapeutic strategies.
  • Recent advancements in understanding inflammatory mediators and cytokines have informed new treatments.

Purpose of the Study:

  • To elucidate asthma management principles across different age groups.
  • To detail allergen avoidance strategies, available pharmacotherapies, and immunotherapy indications.

Main Methods:

  • Literature review utilizing MEDLINE database.
  • Consultation of leading allergy and immunology textbooks.

Main Results:

  • Immunotherapy (IT) shows optimal response in highly sensitive patients with unavoidable allergens and initial late-phase asthmatic responses.

Related Experiment Videos

  • Early consideration of IT may prevent asthma from progressing to severe, less reversible stages.

    • Conclusions:

    • Optimal asthma therapy is individualized, determined by patient-physician collaboration.
    • Effective asthma treatment aims to eliminate both early- and late-phase airway reactivity.
    • New insights into cytokines and mediators enhance understanding of IT and preventive measures.